Skip to main content
. Author manuscript; available in PMC: 2023 Sep 13.
Published in final edited form as: J Alzheimers Dis. 2022;85(3):1233–1250. doi: 10.3233/JAD-215149

Table 10.

Group difference comparisons of different biomarkers at baseline tests (from the AZ APOE cohort).

Biomarker Group Comparisons Average Baseline ± Std Inferential Statistical

UMI NC vs. HM 11.11±3.03 vs. 12.45±3.21 F=3.85; p=0.053
NC vs. HT 11.11±3.03 vs. 11.28±2.98  F=0.09; p=0.77
HT vs. HM 11.28±2.98 vs. 12.45±3.21 F=2.76; p=0.10

UMI-RD NC vs. HM 10.83±3.22 vs. 11.42±5.12 F=0.45; p=0.50
NC vs. HT 10.83±3.22 vs. 11.04±4.27 F=0.08; p=0.80
HT vs. HM 11.04±4.27 vs. 11.42±5.12 F=0.13; p=0.72

Volume
×1000
NC vs. HM 9.924±0.89 vs. 9.933±0.91 F=0; p=0.96
NC vs. HT 9.924±0.89 vs. 9.931±1.04 F=0; p=0.97
HT vs. HM 9.931±1.04 vs. 9.933±0.91 F=0; p=0.99